Eli Lilly (NYSE: LLY) announced a global research collaboration with Seamless Therapeutics to develop programmable gene ...

Patients will be able to find out whether they have genes linked to cancer using a world-leading tool developed by the NHS.

RICHMOND, Va. (WRIC) — A group of scientists at Virginia Commonwealth University (VCU) may have the key to discovering cancer’s origins within the body, as well as insights into new treatment ...

Women with certain genetic mutations are at extremely high risk of ovarian cancer. Now, some researchers are trying a new ...

SALT LAKE CITY, Sept. 06, 2023 (GLOBE NEWSWIRE) -- Myriad Genetics (MYGN), Inc. (NASDAQ:MYGN), a leader in genetic testing and precision medicine, today revealed new nationwide survey results ...

Leading genomic health experts from Monash University are calling for urgent government funding to progress the development ...

Genetic tests for cancer on NHS to help families detect ‘Jolie’ gene - Health secretary Wes Streeting has backed the plans ...

For Josh Henderson, 66, of Olympia, getting genetic testing was a no-brainer. “The first time I came to Fred Hutch, my oncologist suggested it,” said the retired IT manager who received a metastatic ...

A new study explains the genetic underpinnings of a rare and aggressive form of ovarian cancer – and offers a potential pathway for new treatments. High-grade serous carcinoma, the most common type of ...

A systematic review found that bilateral salpingectomy is associated with roughly an 80% reduction in risk for the serous ...